Gordon Dunn - 09 Sep 2024 Form 4 Insider Report for Quoin Pharmaceuticals, Ltd. (QNRX)

Role
Chief Financial Officer
Signature
/s/ Gordon Dunn
Issuer symbol
QNRX
Transactions as of
09 Sep 2024
Net transactions value
+$23,205
Form type
4
Filing time
11 Sep 2024, 16:30:08 UTC
Previous filing
30 Oct 2023
Next filing
10 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNRX Ordinary Shares Purchase $685 +856 $0.8000 856 09 Sep 2024 Direct F1
transaction QNRX Ordinary Shares Purchase $3,120 +4,000 +467% $0.7800 4,856 09 Sep 2024 Direct F1
transaction QNRX Ordinary Shares Purchase $3,200 +4,000 +82% $0.8000 8,856 09 Sep 2024 Direct F1
transaction QNRX Ordinary Shares Purchase $9,100 +10,000 +113% $0.9100 18,856 10 Sep 2024 Direct F1
transaction QNRX Ordinary Shares Purchase $7,100 +10,000 +53% $0.7100 28,856 10 Sep 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary shares of the Issuer.